How much pics i can upload

You can upload 1 image at a time per message. There's no hard cap on the total number of images across a conversation, but each message supports a single image attachment.

If you have multiple images to share, just send them in separate messages one by one!

Is there any limit for one day .

There is no daily limit on how many images you can upload in this chat. You can send as many images as you need, one per message, throughout the day.

Just keep sending them whenever you're ready!

IMG_2222.jpg

IMG_2223.jpg

Explain in detail

analyse_media

Diabetes in Pregnancy - Detailed Notes

PART 1

1. Carbohydrate Metabolism in Pregnancy

Insulin Resistance (IR) in pregnancy:

Pregnancy is a diabetogenic state because of hormones that cause insulin resistance:

HPL (Human Placental Lactogen) - main culprit
Estrogen, Progesterone, Prolactin (PRL), Cortisol
hCG - does NOT cause insulin resistance

As gestation progresses, HPL secretion increases, increasing IR. Significant IR develops around 24-28 weeks of gestation.

Key placental transfer facts:

Substance	Crosses Placenta?
Maternal insulin	NO
Maternal glucose	YES
Maternal thyroxine	YES

Fetus is entirely dependent on mother for glucose.
Glycosuria is normal in pregnancy.

2. Pregnancy Complications of Diabetes

Fetal complications:

Maternal glucose crosses placenta → fetus absorbs it → fetal hyperglycemia
Fasting hypoglycemia (advice: avoid fasting)
Post-prandial hypoglycemia (due to IR)
Fasting/vomiting/diarrhea → Hypoglycemia → Acetone bodies → Ketosis

High-risk pregnancy mechanism:

Hyperglycemia → feto-toxic → ↑↑ Free radicals → cross placenta → Congenital malformations of fetus

3. Classification of Diabetes in Pregnancy

Feature	Pre-gestational Diabetes	Gestational Diabetes (GDM)
Who	Diabetic female conceives	Normoglycemic female conceives
Blood sugar ↑	From Day 1	From 24-28 weeks
Free radicals	Form from day 1	Begin forming after 24-28 wks (after organogenesis)
Congenital malformations	YES	NO (radicals form after organogenesis)
Resolves after delivery?	NO	YES - within 6 weeks

4. Priscilla White Classification

              Priscilla White Classification
                         |
          --------------------------------
         |                              |
       Type A                        Non-Type A
  Gestational Diabetes           Pregestational Diabetes
         |
    -----------
   A1           A2
GDM on diet    GDM on Rx
             (Insulin / Metformin)

Development of GDM:

Usually at 24-28 weeks
Can be seen earlier (<20 wks) → usually pre-GDM
Confirmed: Repeat sugar level at 6 weeks postpartum

5. Investigations for GDM

TIFFA (Targeted Imaging for Fetal Anomalies): Done in all GDM + Pre-GDM at 18-20 weeks

Management trigger:

2hr PP blood sugar ≥ 200 mg/dL → Always give Insulin (irrespective of GDM or Pre-GDM)

PART 2: Pregestational Diabetes

6. Criteria for Pregestational Diabetes

Test	Cut-off
FBS	≥ 126 mg/dL
2hr PPBS	≥ 200 mg/dL
RBS	≥ 200 mg/dL
HbA1c	≥ 6.5%

DIPSI Test: Recommended by Govt. of India at 1st ANC visit

7. HbA1c - Risk Assessment for Congenital Anomalies

HbA1c	Risk of Gross Congenital Anomalies (GCA)
< 6.5%	No risk
> 6.5%	3% risk
≥ 10%	15-20% risk

Goal of therapy: HbA1c < 6%

8. Investigations

Initial: USG
Screening: Level I USG
Diagnostic: TIFFA
Karyotyping: NOT done (detects chromosomal anomalies, not GCA)

9. Congenital Fetal Malformations

Category	Most Common
System involved	CVS > CNS
Congenital malformation	VSD (Ventricular Septal Defect) > NTD (Neural Tube Defect)
Cardiac malformation	VSD
Most SPECIFIC cardiac anomaly	TGA (Transposition of Great Arteries)
Cardiac finding	HOCM (Hypertrophic Obstructive Cardiomyopathy)

Caudal Regression Syndrome - classic malformation seen in diabetic mothers (shown in image).

Prevention of GCA:

Strict glucose control (HbA1c < 6.5% = nil risk)
Switch to insulin before conception / on confirmation of pregnancy
Folic acid 400 mcg/day
- Begin 1 month before conception
- Continue for 3 months post conception

PART 3: Other Complications of Pre-GDM

10. Other Complications

PIH (Pregnancy Induced Hypertension)
Polyhydramnios
Infections (asymptomatic bacteriuria)
↑ IR throughout pregnancy
Fetal macrosomia

11. Management (Antenatal Visits)

At each visit:

Measure weight
Check BP
Urine dipstick for proteinuria
Blood glucose monitoring:
- 2nd trimester: every 2 weeks
- 3rd trimester: every week
Fundal examination: rule out diabetic retinopathy

Investigations:

Type	Details
USG	Level I screening → TIFFA at 18-20 wks → Fetal ECHO at 22-24 wks (rule out VSD)
Urine	Routine + microscopy every trimester (rule out asymptomatic bacteriuria) ± culture & sensitivity
Fetal monitoring	Begin at 32 weeks: NST (weekly), BPS (weekly), Growth scan (3-weekly)
Growth scans	At least 2 scans: at 28-30 wks and 34-36 wks (minimum gap: 3 weeks)

Umbilical Artery Doppler - indications:

Diabetic vasculopathy
Development of PIH

Note: All above investigations are done in GDM except Fetal ECHO (no CVS anomaly suspicion in GDM).

12. Treatment

Medical Management:

Weight counselling
Medical Nutrition Therapy (MNT) / diet modification
Insulin - DOC (Drug of Choice) for diabetes in pregnancy
Low-dose aspirin (to prevent PIH)

Obstetric Management:

TOP/IOL (Termination / Induction of labour): ≥ 39 weeks
Mode of delivery: Vaginal (preferred)
Indication for C-section: Baby weight ≥ 4.5 kg

PART 4: Gestational Diabetes (GDM)

13. GDM Features

Occurs due to ↑ IR in normoglycemic female
Complications: Similar to Pre-GDM except no congenital anomalies (GCA)
Follow-up: Same as Pre-GDM
Investigations: Same as Pre-GDM except Fetal ECHO not done

14. DIPSI Criteria (Diagnosis of GDM)

Recommended by Govt. of India

Testing schedule:

1st test: at 1st antenatal visit
Repeat: at 24-28 weeks (minimum gap from 1st = 4 weeks)
If 1st visit is after 28 weeks: Only 1 test

Procedure:

No fasting needed (universal screening)
Irrespective of previous meals
Give 75g glucose in 300 mL water (can add lime) - consume in 5-10 minutes
Check 2-hour PP levels using plasma-calibrated glucometer

If patient vomits:

Within 30 minutes → Repeat test on another day
After 30 minutes → Continue test

These notes cover the complete topic of Diabetes in Pregnancy including pathophysiology, classification, complications, investigations, diagnosis (DIPSI), and management. Let me know if you want any section explained further or need MCQ-style revision points!

What is 40 40 20 rule to control GDM on diet

The 40-40-20 rule is a dietary distribution guideline used in Medical Nutrition Therapy (MNT) for controlling GDM. Here is what it means:

40-40-20 Rule for GDM Diet Control

This rule refers to the distribution of daily calorie intake across meals:

Meal	Calorie Share
Breakfast	40%
Lunch	40%
Dinner	20%

The logic behind keeping dinner at only 20% is that insulin sensitivity is lowest at night, so a lighter dinner prevents nocturnal hyperglycemia.

Additional Dietary Guidelines in GDM

Total calories: ~30-35 kcal/kg/day (based on pre-pregnancy weight)
Carbohydrate restriction: 40-45% of total calories (complex carbs preferred)
Protein: ~20-25%
Fat: ~30-35%
Frequent small meals are preferred over 3 large meals to avoid post-prandial glucose spikes
No simple sugars / refined carbohydrates
High fiber diet - slows glucose absorption

Goal of Dietary Control (A1 GDM)

FBS < 95 mg/dL
2hr PP < 120 mg/dL
If targets not met on diet alone → escalate to insulin (move from A1 to A2 GDM)

Note: This rule is specifically relevant for the Priscilla White Class A1 (GDM controlled on diet alone). If diet fails to control blood sugar, the patient is reclassified as A2 and started on insulin or metformin.

Let me know if you want MCQ points or more detail on any aspect!

What is sacral agenesis

Finding Sources

Reading File

Loading Image

Sacral Agenesis (Caudal Regression Syndrome)

Definition

Sacral agenesis is a rare congenital anomaly in which part or all of two or more sacral (and sometimes lumbar) vertebral bodies are absent. It occurs early in fetal development due to failure of ossification of the lowest vertebral segments.

It is the hallmark malformation associated with maternal diabetes (especially poorly controlled pre-gestational diabetes).

Comprehensive Clinical Nephrology, 7th Ed

Alternate Name

Caudal Regression Syndrome - the broader term that encompasses sacral agenesis along with associated lower limb and visceral anomalies.

Cause / Pathogenesis

Factor	Detail
Primary association	Maternal Type 1 diabetes (poorly controlled)
Mechanism	Hyperglycemia → ↑↑ free radicals → cross placenta → disrupt caudal mesoderm development in early embryogenesis
Embryologic defect	Incomplete tubularization of neural tube + inadequate mesodermal invagination → arrest of vertebral arch / sacral formation
Drug cause	Minoxidil (rare maternal drug exposure)
Genetic	Familial cases linked to Currarino syndrome
Timing	Occurs during organogenesis (1st trimester) - which is why Pre-GDM (not GDM) causes it

Key exam point: GDM does NOT cause congenital malformations because hyperglycemia starts at 24-28 weeks, AFTER organogenesis is complete.

Classification (Renshaw / Partial-Complete)

Types of Sacral Agenesis - A: Type I (unilateral partial), B: Type II (bilateral symmetric partial, stable), C: Type III (total sacral + variable lumbar, ilia articulate with lowest vertebra), D: Type IV (total sacral + lumbar, caudal endplate rests above fused ilia)

Type	Description
Type I	Total or partial unilateral sacral agenesis
Type II	Partial sacral agenesis, bilateral symmetric, stable articulation with normal/hypoplastic S1
Type III	Variable lumbar + total sacral agenesis; ilia articulate with lowest vertebra
Type IV	Variable lumbar + total sacral agenesis; lowest vertebra rests above fused ilia

Campbell's Operative Orthopaedics, 15th Ed

Clinical Features

Musculoskeletal:

Characteristic "sitting Buddha" posture of lower limbs
Foot deformities
Knee flexion contractures with popliteal webbing
Hip flexion contractures
Dislocated hips
Spinal-pelvic instability
Scoliosis
Bone prominence at the last vertebral segment (visible on inspection of back)
Gross motion between vertebral prominence and pelvis

Neurological:

Motor power intact down to level of lowest vertebra with pedicles
Sensation is preserved at up to 3 dermatome levels lower than functional motor control
Even severe cases may retain some function

Visceral:

Genitourinary anomalies (very common)
- Neurogenic bladder → urinary incontinence, recurrent UTIs
Anorectal anomalies
- Stool incontinence

Outcome:

Significant orthopedic disability (similar to paraplegia)
Mental function is typically preserved

Antenatal Diagnosis

Ultrasound findings:

Sacral agenesis on fetal ultrasound - abrupt termination of spine at lumbosacral region (arrowheads); T = thoracic, C = cervical

Abrupt termination of spine at lumbosacral region on USG
Echolucent mass caudal to defect (accumulated fetal urine)
In axial view: cord insertion seen anteriorly but spine absent posteriorly
3D fetal MRI or 3D skeletal imaging used for confirmation

Screening:

Detected on TIFFA / targeted anomaly scan at 18-20 weeks
Amniocentesis + microarray / NIPT considered for karyotype
Karyotyping is NOT the primary tool (it detects chromosomal anomalies, not GCA)

HbA1c Risk Correlation

HbA1c	Risk of GCA (including sacral agenesis)
< 6.5%	Nil
> 6.5%	3%
≥ 10%	15-20%

Prevention

Strict glycemic control before conception (HbA1c < 6.5%)
Switch to insulin before/at conception
Folic acid 400 mcg/day starting 1 month before conception

Quick Exam Summary

Point	Fact
Also called	Caudal Regression Syndrome
Caused by	Pre-gestational diabetes (NOT GDM)
Mechanism	Hyperglycemia → free radicals → teratogenesis in 1st trimester
Classic posture	"Sitting Buddha"
Most specific cardiac anomaly in diabetic mother	TGA
Mental function	Preserved
Detected by	USG / TIFFA at 18-20 weeks

Explain fetal monitoring

Finding Sources

Reading File

I now have comprehensive data. Here is the full detailed explanation:

Fetal Monitoring - Complete Explanation

Fetal monitoring is the ongoing assessment of fetal well-being during antenatal period and labor, using a combination of clinical and electronic tests. It relies on the principle that fetal neurologic status is closely coupled to cardiovascular reflex responses.

Why Fetal Monitoring?

The goal is to detect fetal hypoxia, acidosis, and uteroplacental insufficiency early enough to intervene. In high-risk pregnancies (diabetes, hypertension, IUGR, post-term), fetal monitoring is intensified.

As noted in our previous discussion on diabetes in pregnancy, fetal monitoring begins at 32 weeks in Pre-GDM/GDM patients, with NST and BPS done weekly.

Methods of Fetal Monitoring

1. Non-Stress Test (NST)

Principle: A healthy fetus with an intact CNS will show acceleration of heart rate with its own movements. FHR (Fetal Heart Rate) acceleration = sign of fetal well-being.

Criteria for REACTIVE NST (Normal/Reassuring):

At least 2 FHR accelerations in a 20-30 minute period
Each acceleration must:
- Rise ≥ 15 beats/min above baseline
- Last ≥ 15 seconds

Modification for preterm (<32 weeks):

Acceleration of ≥ 10 beats/min lasting ≥ 10 seconds (smaller accelerations are normal in younger fetuses)

Result	Meaning
Reactive	Normal - fetus is well oxygenated
Non-reactive	Abnormal - may indicate hypoxia, CNS depression, sleep cycle, or drug effect

Non-reactive NST - causes:

Fetal sleep cycle (most common - normal cause)
Prematurity
Fetal growth restriction (FGR)
Maternal medications (narcotics, magnesium sulfate)
CNS abnormality or prior CNS injury
True fetal compromise

Important: A non-reactive NST with preserved FHR variability and no decelerations is most likely a sleep cycle, NOT fetal compromise. Always back up with BPP.

False negative rate: 1.9 per 1000 fetuses (fetal death within 1 week of a reactive NST).

Frequency in diabetes (from notes): Weekly from 32 weeks.

2. Biophysical Profile Score (BPS/BPP)

Principle: Multiple parameters together are better predictors of fetal well-being than any single parameter.

5 Variables - each scored 2 (normal) or 0 (abnormal):

Variable	Normal (Score = 2)	Abnormal (Score = 0)
NST	Reactive (≥2 accelerations)	Non-reactive
Fetal Breathing Movements (FBM)	≥1 episode of ≥30 sec in 30 min	Absent or < 30 sec
Fetal Movements (FM)	≥3 discrete body/limb movements in 30 min	< 3 movements
Fetal Tone (FT)	≥1 episode of active limb extension + return to flexion	Absent or slow return
Amniotic Fluid Volume (AFV)	Single deepest pocket ≥ 2 cm in 2 perpendicular planes	Pocket < 2 cm

Maximum total score = 10

Interpretation of BPP Score:

Score	Interpretation	Action
8-10	Normal, no fetal compromise	Routine care
6	Equivocal	Repeat in 24 hrs; consider delivery if at term
4	Suspected fetal compromise	Delivery in most cases
0-2	Strong evidence of fetal compromise	Immediate delivery

Modified BPP: NST + Amniotic fluid volume only (simpler, faster screening).

3. Amniotic Fluid Volume (AFV) Assessment

Principle: Decreased amniotic fluid (oligohydramnios) in an anatomically normal fetus = fetal oliguria = redistribution of blood flow away from kidneys = uteroplacental insufficiency.

Measurement technique (for BPP):

Transducer held vertical to maternal abdomen
Measure the maximum vertical depth of a clear fluid pocket
Rotate 90° to confirm it is a true 3D pocket
The 2×2 pocket rule: pocket must be ≥ 2 cm deep in at least 2 intersecting planes

Amniotic Fluid Index (AFI): Sum of deepest pockets in all 4 quadrants.

Normal AFI: 8-24 cm
Oligohydramnios: AFI < 5 cm
Polyhydramnios: AFI > 24 cm

Avoid using continuous color Doppler when measuring - can falsely suggest oligohydramnios by mistaking cord loops for fluid.

4. Umbilical Artery Doppler Velocimetry

Principle: Umbilical arteries carry no somatic branches - they purely mirror downstream placental resistance. Normally, resistance falls progressively through pregnancy as more placental vessels develop.

Indications in diabetes (from notes):

Diabetic vasculopathy
Development of PIH

Progression of abnormality:

Stage	Finding	Significance
Normal	Positive end-diastolic flow, falling resistance through pregnancy	Well-being
Early compromise	Elevated S/D ratio (↑ resistance)	Placental dysfunction
Worsening	AEDV - Absent End-Diastolic Velocity	Severe compromise
Critical	REDV - Reversed End-Diastolic Velocity	Imminent fetal death, deliver immediately

S/D ratio (Systolic/Diastolic): Falls normally from 1st to 3rd trimester.

Umbilical artery Doppler showing progression from normal to AEDV to REDV

5. Fetal Heart Rate (FHR) Monitoring / Cardiotocography (CTG)

Used in labor. Assesses fetal heart rate patterns continuously.

Key FHR parameters:

Parameter	Normal
Baseline FHR	110-160 bpm
Variability	6-25 bpm (moderate variability = reassuring)
Accelerations	≥15 bpm rise for ≥15 sec (reactive)
Decelerations	Absent / early only (late/variable = concerning)

Types of decelerations:

Type	Timing relative to contraction	Cause	Significance
Early	Mirror contraction (simultaneous)	Head compression	Benign
Late	After peak of contraction	Uteroplacental insufficiency	Pathological
Variable	No fixed relationship	Cord compression	May be pathological if persistent

FHR Classification (ACOG):

Category I (Normal): Baseline 110-160, moderate variability, no late/variable decels
Category II (Indeterminate): Does not fit I or III
Category III (Abnormal): Sinusoidal pattern OR absent variability with recurrent late/variable decelerations → immediate action

6. Growth Scan (Fetal Biometry on USG)

Purpose: Detect macrosomia or IUGR.

In diabetic pregnancy (from notes):

Done 3-weekly (to rule out polyhydramnios and macrosomia)
At least 2 growth scans:
- At 28-30 weeks
- At 34-36 weeks
- Minimum gap between scans: 3 weeks

Parameters measured:

BPD (Biparietal Diameter)
HC (Head Circumference)
AC (Abdominal Circumference)
FL (Femur Length)
Estimated Fetal Weight (EFW)

Summary Table: Fetal Monitoring Schedule in Diabetes

Test	When	Frequency
NST	From 32 weeks	Weekly
BPS (Biophysical Score)	From 32 weeks	Weekly
Growth scan	28-30 wks & 34-36 wks	3-weekly (min 2 scans)
Umbilical artery Doppler	If vasculopathy / PIH	As indicated
TIFFA	18-20 weeks	Once
Fetal ECHO	22-24 weeks (Pre-GDM only)	Once

Key Exam Points

Point	Fact
NST starts at	32 weeks in diabetic pregnancy
Reactive NST	≥2 accelerations of ≥15 bpm for ≥15 sec
Most common cause of non-reactive NST	Fetal sleep cycle (normal)
BPP maximum score	10
Score 8-10	Normal
Score ≤4	Deliver
Most ominous Doppler finding	REDV (Reversed End-Diastolic Velocity)
Oligohydramnios on BPP	Deepest pocket < 2 cm
Fetal ECHO NOT done in	GDM (only Pre-GDM)

Creasy & Resnik's Maternal-Fetal Medicine, Principles and Practice

Make summary of cvs from ghai textbook of peditrics

Finding Sources

Unfortunately, Ghai's Textbook of Pediatrics is not available in the medical library. The library only has two pediatric books:

The Harriet Lane Handbook (Johns Hopkins, 23rd ed.)
Red Book 2021 (Committee on Infectious Diseases)

What I Can Do Instead

Here are your options:

1. CVS summary from a different pediatric source - I can pull CVS (Cardiovascular System) content from Harriet Lane Handbook or any other available cardiology textbook (e.g., Braunwald's Heart Disease).

2. CVS summary based on Ghai topics from my training knowledge - I can write a detailed topic-wise summary covering what Ghai covers in its CVS chapter (congenital heart diseases, rheumatic fever, cardiac failure in children, etc.) based on my knowledge of the book's content.

3. Upload your Ghai PDF - If you have a PDF of the relevant Ghai CVS chapter, you can upload it and I will extract and summarize it for you.

Which would you prefer? Or if you want all key CVS pediatric topics (ASD, VSD, TOF, PDA, rheumatic fever, cardiac failure) summarized in detail, I can do that right away from available sources combined with Ghai-style content.

This is a shared conversation. Sign in to Orris to start your own chat.